A Breakthrough in Respiratory Physiology: Inhaled Nitric Oxide Transported as SNO-Hb

Key Points

• Inhaled nitric oxide (NO) increases circulating levels of SNO-Hb, a bioactive form of NO

• Inhaled NO also increases circulating levels of nitrite, another NO metabolite

• The lungs might act as a reservoir of SNO-Hb, releasing it into circulation as needed

The Breathing Diabetic Summary

Inhaled nitric oxide (NO) has many systemic impacts.  An overview of these effects can be found here and here.  However, it has remained unclear how inhaled NO exerts these effects.  In general, inhaled NO is believed to react and become inactive after reaching the lungs.  Thus, conventional thinking is that the systemic effects of NO are due to improved gas exchange in the lungs, which then has positive downstream impacts.

Interestingly, despite its widespread clinical use, there have been very few studies testing this hypothesis to truly discover how inhaled NO exerts its systemic effects.  This paper sought to fill that gap.

To do this, they recruited 15 healthy volunteers.  They had them inhale NO at concentrations of 40 ppm (the maximum produced in the paranasal sinuses is on the order of ~20 ppm, but typically much less).  They inhaled the added NO for 15 minutes.  Blood samples were collected before inhalation, at the end of the 15 minutes of inhalation, and then at 5, 15, and 30 minutes post-inhalation. 

A Breakthrough in Cardio-Respiratory Physiology

The results were striking.  They found that NO inhalation significantly increased circulating levels of SNO-Hb and nitrite.  This is important because SNO-Hb plays a significant role in whole-body oxygenation.  A 2015 PNAS study discovered that SNO-Hb “senses” areas of low oxygen, and then releases bioactive NO to increase blood flow and oxygenation.  This discovery led to breathing be considered as a three-gas system involving oxygen, carbon dioxide, and NO.  Thus, if inhaling NO increases SNO-Hb, it could be playing a critical role in whole-body oxygenation.  This gets even more intriguing (see next two sections), but first, let’s cover their nitrite finding.

They also observed increases in circulating nitrite.  This is important because, like SNO-Hb, nitrite can also release bioactive NO in regions of hypoxia. However, nitrite can do this independent of the hemoglobin, thus providing a “back-up mechanism” for increasing blood flow in regions of low oxygen.

The Lungs as a Reservoir of SNO-Hb

An interesting finding from this study was that nitrite levels were most significant at the 5-min post inhalation mark.  In contrast, SNO-Hb continued rising throughout the 30 minutes.  This led the authors to believe that the lungs might be acting as an SNO-Hb reservoir, releasing it "as needed." 

Why These Findings Matter

When we breathe through our nose, we carry NO into the lungs (although not at concentrations as high as those studied here).  Based on these findings, we can now be reasonably confident this NO enters the bloodstream and is carried as SNO-Hb and nitrite.  Thus, breathing through your nose might not just improve gas exchange in the lungs.  It might also help make sure oxygen gets delivered where it is needed most throughout the body. 

Additionally, their finding that SNO-Hb levels continued increasing after NO inhalation is intriguing.  It might support the idea that nose breathing provides a baseline level of NO that keeps SNO-Hb in its normal range.  Then, when excess NO is inhaled, the body stores that "just in case."  This is speculative, but interesting to contemplate.

Finally, this is one study, and it’s relatively new.  We’ll need more to confirm/deny that NO inhalation consistently increases SNO-Hb and nitrite across different populations.  In the meantime, let’s keep breathing through our noses.  It may just be the key to whole-body oxygenation.

Abstract

Rationale: Inhaled nitric oxide (NO) exerts a variety of effects through metabolites and these play an important role in regulation of hemodynamics in the body. A detailed investigation into the generation of these metabolites has been overlooked. 

Objectives: We investigated the kinetics of nitrite and S-nitrosothiol-hemoglobin (SNO-Hb) in plasma derived from inhaled NO subjects and how this modifies the cutaneous microvascular response.

Findings: We enrolled 15 healthy volunteers. Plasma nitrite levels at baseline and during NO inhalation (15 minutes at 40 ppm) were 102 (86-118) and 114 (87-129) nM, respectively. The nitrite peak occurred at 5 minutes of discontinuing NO (131 (104-170) nM). Plasma nitrate levels were not significantly different during the study. SNO-Hb molar ratio levels at baseline and during NO inhalation were 4.7E-3 (2.5E-3-5.8E-3) and 7.8E-3 (4.1E-3-13.0E-3), respectively. Levels of SNO-Hb continued to climb up to the last study time point (30 min: 10.6E-3 (5.3E-3-15.5E-3)). The response to acetylcholine iontophoresis both before and during NO inhalation was inversely associated with the SNO-Hb level (r: -0.57, p = 0.03, and r: -0.54, p = 0.04, respectively).

Conclusions: Both nitrite and SNO-Hb increase during NO inhalation. Nitrite increases first, followed by a more sustained increase in Hb-SNO. Nitrite and Hb-SNO could be a mobile reservoir of NO with potential implications on the systemic microvasculature.

Journal Reference:

Tonelli AR, Aulak KS, Ahmed MK, Hausladen A, Abuhalimeh B, Casa CJ, Rogers SC, Timm D, Doctor A, Gaston B, Dweik RA. A pilot study on the kinetics of metabolites and microvascular cutaneous effects of nitric oxide inhalation in healthy volunteers. PLoS One. 2019 Aug 30;14(8):e0221777. doi: 10.1371/journal.pone.0221777. PMID: 31469867; PMCID: PMC6716644.

A Concise Review of Inhaled Nitric Oxide’s Systemic Impacts

Key Points

• The classical viewpoint that inhaled nitric oxide (NO) only has local effects cannot explain observations.

• For example, inhaled NO has many systemic effects, including the ability to selectively increase blood flow where it is needed most.

• SNO-Hb might be the likely candidate for how inhaled NO is transferred into the blood and transported throughout the body while retaining its bioactivity.

The Breathing Diabetic Summary

This paper presented a concise review of inhaled NO’s systemic effects.  So, I’ll keep the summary brief as well. 

The classical view that inhaled NO only has local effects in the airways and lungs is not supported by observations.  It turns out that inhaled NO has many systemic effects.  Notably, inhaled NO selectively increases blood flow where it is needed most.  Thus, our bodies have a way of using inhaled NO other than just in the airways and lungs.  It can also be transported to distant regions where blood flow is restricted, resulting in vasodilation and increased blood flow.  This was also shown in the Cannon et al. (2001) study.   

Here, as in that study and others, the precise mechanism for how this is done is unknown.  However, there is one pathway that has been brought up repeatedly, which is SNO-Hb.  As we learned in a 2015 PNAS study, SNO-Hb is critical to blood flow regulation and oxygen delivery.  It “senses” regions of hypoxia, releases bioactive NO, and improves blood flow to get more oxygen to the tissues.

The authors suspect that this is also the mechanism by which inhaled NO is selectively improving blood flow, stating that this pathway “likely represents an important mechanism by which inhaled NO can cause systemic effects.”  The difficulty is that SNO-Hb is hard to measure; therefore, there have been no conclusive studies to show that this is the mechanism by which inhaled NO works. 

Altogether, this paper shows that the traditional view of inhaled NO is not adequate to explain its systemic effects.  It’s selective vasodilating effects suggest that SNO-Hb is the mechanism by which inhaled NO is transported throughout the body.  Still, more studies are needed to support this hypothesis.

Abstract

Many effects of inhaled nitric oxide (NO) are not explained by the convention that NO activates pulmonary guanylate cyclase or is inactivated by ferrous deoxy- or oxyheme. Inhaled NO can affect blood flow to a variety of systemic vascular beds, particularly under conditions of ischemia/reperfusion. It affects leukocyte adhesion and rolling in the systemic periphery. Inhaled NO therapy can overcome the systemic effects of NO synthase inhibition. In many cases, these systemic-NO synthase-mimetic effects of inhaled NO seem to involve reactions of NO with circulating proteins followed by transport of NO equivalents from the lung to the systemic periphery. The NO transfer biology associated with inhaled NO therapy is rich with therapeutic possibilities. In this article, many of the whole-animal studies regarding the systemic effects of inhaled NO are reviewed in the context of this emerging understanding of the complexities of NO biochemistry.

Journal Reference:

Gaston B. Summary: systemic effects of inhaled nitric oxide. Proc Am Thorac Soc. 2006 Apr;3(2):170-2. doi: 10.1513/pats.200506-049BG. PMID: 16565427.

Evidence of Systemic Transport and Delivery of Inhaled Nitric Oxide

Key Points

• Inhaled nitric oxide (NO) is traditionally thought to only have local effects in the upper airways and lungs.

• However, this study found that inhaled NO can improve blood flow in distant regions when endothelial NO is suppressed. The measurements were consistent with systemic transport and delivery of inhaled NO.

• The effects of inhaled NO on systemic blood flow might be important in diseases that disrupt endothelial-derived NO (such as diabetes).

The Breathing Diabetic Summary

There are two primary sources of nitric oxide (NO) in the body: inhaled NO and endothelial-derived NO.

Inhaled NO is produced in the paranasal sinuses.  When you breathe through your nose, you bring this NO into your lungs, where it aids in blood flow redistribution and increases oxygen uptake.  However, it is traditionally thought that this NO only affects the airways and lungs; it is said to immediately react and lose its bioactivity.  Although there are many benefits of inhaled NO in the lungs, its journey ends there. 

Endothelial-derived NO, on the other hand, has systemic effects in the body, including improving whole-body blood flow and, especially, blood flow to the heart.  However, it is thought that there is a complete disconnect between these two sources of NO: Inhaled NO does not have systemic effects. 

But several studies suggest otherwise (see review here).  The reported systemic effects of inhaled NO imply it is somehow retaining its bioactivity and being transported throughout the body.  But, it’s now quite sure how. 

This study did something interesting to try to find out. They administered L-NMMA, which inhibits endothelial-derived NO from being produced. Then, they measured what happened to forearm blood flow under several conditions:

1. When participants breathed normal air.

2. During a handgrip exercise (which should increase blood flow).

3. During inhalation of extra NO (at 80 ppm) and repeat the two measurements (sitting still and the handgrip exercise). Note that 80 ppm is much higher than what is produced in the paranasal sinuses, which maxes out around 25 ppm.

4. Lastly, they had participants inhale the added NO without using L-NMMA, which, as we will see, turns out to be a critical measurement.

The results were quite fascinating.  First, when NO was inhaled without the L-NMMA administered, nothing happened to forearm blood flow.  Therefore, under normal conditions, inhaling extra NO doesn’t seem to impact blood flow.  But things got interesting when L-NMMA was administered.  Inhaling NO counteracted the blood flow reduction due to L-NMMA.

Thus, under normal conditions, inhaled NO doesn’t have much impact on systemic blood flow.  But, when endothelial-derived NO is suppressed (the L-NMMA case), the inhaled NO “takes over,” compensating for the missing NO.  This opens up the blood vessels and increases blood flow.  This effect was most marked during the handgrip exercise.

Moreover, by looking at arterial-to-venous gradients in different gases, which show how gases change from when the blood leaves the lungs versus when it returns to the heart, they found evidence of NO transport and delivery.  This led them to conclude:

“The most fundamental and important observation of this study is that NO gas introduced to the lungs can be stabilized and transported in blood and peripherally modulate blood flow.” 

This study was groundbreaking in that it showed, for the first time, evidence of inhaled NO being transported throughout the body while maintaining its bioactivity.  These results might be significant to diabetics because we suffer from reduced endothelial-derived NO and reduced blood flow.  Thus, the results might provide more support for nose-breathing (although again, NO concentrations in the nose are far less than what was administered here).

To conclude, I’ll borrow a line from the abstract, which succinctly states how the findings of this study could be particularly important to diabetics: 

“These results indicate that inhaled NO during blockade of regional NO synthesis can supply intravascular NO to maintain normal vascular function. This effect may have application for the treatment of diseases characterized by endothelial dysfunction.”

Abstract

Nitric oxide (NO) may be stabilized by binding to hemoglobin, by nitrosating thiol-containing plasma molecules, or by conversion to nitrite, all reactions potentially preserving its bioactivity in blood. Here we examined the contribution of blood-transported NO to regional vascular tone in humans before and during NO inhalation. While breathing room air and then room air with NO at 80 parts per million, forearm blood flow was measured in 16 subjects at rest and after blockade of forearm NO synthesis with NG-monomethyl-l-arginine (l-NMMA) followed by forearm exercise stress. l-NMMA reduced blood flow by 25% and increased resistance by 50%, an effect that was blocked by NO inhalation. With NO inhalation, resistance was significantly lower during l-NMMA infusion, both at rest and during repetitive hand-grip exercise. S-nitrosohemoglobin and plasma S-nitrosothiols did not change with NO inhalation. Arterial nitrite levels increased by 11% and arterial nitrosyl(heme)hemoglobin levels increased tenfold to the micromolar range, and both measures were consistently higher in the arterial than in venous blood. S-nitrosohemoglobin levels were in the nanomolar range, with no significant artery-to-vein gradients. These results indicate that inhaled NO during blockade of regional NO synthesis can supply intravascular NO to maintain normal vascular function. This effect may have application for the treatment of diseases characterized by endothelial dysfunction.

Journal Reference:

Cannon RO 3rd, Schechter AN, Panza JA, et al. Effects of inhaled nitric oxide on regional blood flow are consistent with intravascular nitric oxide delivery. J Clin Invest. 2001;108(2):279-287. doi:10.1172/JCI12761

A Review of Nasal Nitric Oxide's Powerful Effects

Key Points

• Nasal nitric oxide (NO) acts as our first line of defense against airborne pathogens by sterilizing incoming air and enhancing cilia movement

• Nasal NO plays a role in warming the air we breathe as it travels into the lungs

• Humming significantly increases nasal NO and could be used as a test for sinus disorders
  

The Breathing Diabetic Summary

I spend a lot of time reading about nitric oxide (NO).  But, the more I learn, the more interested I become. It seems to pop up everywhere I look. Sometimes I wonder what it can’t do.

Nitric oxide’s physiological relevance was discovered in 1987, the same year I was born. Its effects were known several years prior, but it wasn’t until two separate papers (both in prestigious journals, PNAS and Nature) were published that NO’s benefits became “official.”

In the respiratory system, the primary source of NO is the upper airways. The paranasal sinuses, in particular, produce ~90% of the NO measured in exhaled air.  

Previously, we have learned that NO acts as our first line of defense against airborne pathogens by sterilizing incoming air.  The breathing community often touts aspect of NO.  Here, we learn there is more to it: nitric oxide also increases the cilia motility.  

Cilia are tiny hairs lining the back of your nose and respiratory tract. They oscillate back and forth to move mucus out of the upper and lower airways, bringing pathogens and other potentially harmful agents along for the ride.  Cilia are your lung’s first defense against inhaled particles and nitric oxide enhances their activity.  

Nitric oxide also plays a role in warming incoming air. The precise mechanism is unclear, but increased nasal NO release is associated with increased temperature in the nasal airways.

Here is my speculation: NO increases blood flow in your nose, which warms the nasal passages and airways. As air travels through, it extracts this warmth before entering the lungs. Makes sense, but is just a hypothesis and likely oversimplifies what is going on…

Nasal nitric oxide also redistributes blood flow in the lungs when in the upright position, leading to better oxygen uptake. (Nasal NO might even be an adaptation to gravity, allowing us to walk upright.)  

Finally, humming causes a significant increase in nasal NO. However, some sinus disorders inhibit this enhanced NO release. Therefore, the measurement of nasal NO after humming might be a way to test for sinus disorders.

To summarize, nasal nitric oxide is a powerful gas. It acts as our first line of defense against airborne pathogens by sterilizing incoming air and by improving cilia motility. Additionally, NO helps warm the air we breathe as it travels into our lungs. NO also redistributes blood flow in the lungs, resulting in better oxygen uptake. Lastly, humming increases NO significantly and might provide a way to test for sinus disorders.

Abstract

Exhaled nitric oxide (NO) originates from the upper airways, and takes action, to varying extents, in regulation, protection and defense, as well as in noxious processes. Nitric oxide retains important functions in a wide range of physiological and pathophysiological processes of the human body, including vaso-regulation, antimicrobial activity, neurotransmission and respiration. This review article reports the ongoing investigations regarding the source, biology and relevance of NO within upper respiratory tract. In addition, we discuss the role of NO, originating from nasal and paranasal sinuses, in inflammatory disorders such as allergic rhinitis, sinusitis, primary ciliary dyskinesia, and cystic fibrosis.

Journal Reference:

Maniscalco M, Bianco A, Mazzarella G, Motta A.  Recent Advances on Nitric Oxide in the Upper Airways.  Curr Med Chem. 2016;23(24):2736-2745.

Nitric Oxide Might Outweigh All Other Benefits of Nose Breathing

Key Points

• Nasal nitric oxide (NO) acts as our body’s first line of defense against airborne pathogens

• Nasal NO reduces blood pressure, redistributes blood flow, and increases gas exchange

• The humidifying effects of the nose might not be as important as NO

The Breathing Diabetic Summary

Nitric oxide (NO) has, somewhat quietly, become a staple of breathing science.  NO is produced in the nasal airways and carried into the lungs with each (nasal) breath we take.  This review discussed nasal NO, its origins, and its physiological effects in the body.

The general consensus is that NO is produced in the paranasal sinuses and is continuously released into the nasal airways.  Because of this continuous release, NO’s concentration is dependent on flow rate.  A lower flow rate will allow more NO to build up, thus bringing higher concentrations down into the lungs with each breath.   

This could be yet another benefit of slow breathing: Slower flow rates will increase NO. Each breath then brings in a higher concentration of NO, redistributing blood flow, increasing gas exchange, and potentially increasing infection-fighting capabilities.

Which brings us to the next physiological effect of nasal NO: Host defense.  Some bacteria die when NO concentrations are as low as 100 parts per billion (ppb).  In the paranasal sinuses, the concentration can be as great as 30,000 ppb(!).  Thus, nasal NO might be the first line of defense against airborne bacteria, acting to sterilize the incoming air and reduce infection. 

Nasal NO also increases arterial oxygenation and reduces blood pressure in the lungs.  For example, one study showed that nasal breathing increased tissue oxygenation by 10% when compared to mouth breathing.  That’s pretty remarkable.

For example, one study showed that nasal breathing increased tissue oxygenation by 10% when compared to mouth breathing.

Another study showed that when mouth breathers were given supplemental NO, arterial oxygenation increased and and lung blood pressure decreased similar to nose breathing.  Interestingly, if the mouth breathers were just given moistened air (without NO), these effects did not occur.  Thus, the main benefits of nasal breathing might be due to NO, not the warming and humidifying effects that are typically touted (although they clearly help).

Finally, widening the nostrils via nasal tape also increases arterial oxygenation during breathing at rest.  This could partially be due to an increased delivery of NO to the lungs.  We can naturally unblock our noses using simple breath hold techniques or use something like Intake Breathing for assistance.

Overall, this study highlighted several important aspects of nasal NO.  It acts as our body’s first line of defense against airborne pathogens by sterilizing incoming air.  Then, as NO travels into the lungs, it reduces blood pressure, redistributes blood flow, and increases gas exchange, leading to greater arterial oxygenation.  Finally, we learned that the humidifying effects of the nose might not be as important as NO. 

I am continually amazed by the many roles of nitric oxide in the body.  I believe it might be the most important aspect of nasal breathing. 

Journal Reference:

Lundberg JO, Weitzberg E.  Nasal nitric oxide in man.  Thorax.  1999;54(10):947-52.

Nasal Nitric Oxide: Nature’s Answer to Gravity?

Key Points

• Nitric oxide redistributes blood flow in the lungs to be more uniform

• Nitric oxide increases gas exchange in the lungs

• Nasal nitric oxide might be an evolutionary adaptation to counter gravity

The Breathing Diabetic Summary

Blood flow in the lungs is essential for gas exchange and defense against infections. However, lung blood flow is not as uniform as we might think. And, although several factors account for this, gravity plays a significant role.  Gravity acts to focus blood flow toward the bottom of the lungs.  

Interestingly, in humans and higher primates, a large amount of nitric oxide (NO) is released in the nasal passages. As we learned, NO is critical for blood flow and whole-body oxygenation. The authors of this study wondered if nasal NO might also redistribute blood flow in the lungs, thus countering the effects of gravity and increasing gas exchange in the lungs. This adaptation would have allowed us to evolve into the bipedal mammals we are today.

To test this, they examined how different breathing protocols affected lung blood flow. Participants were injected with a radionuclide that acted as a passive tracer of blood flow, which could then be imaged to show relative “heat maps” of blood flow in the lungs.

Fourteen participants were broken into three groups. The first group served as a control to ensure the radiotracer imaging technique worked as intended. The second group was used to see how nasally produced NO affected lung blood flow. These participants sat in an upright position and breathed through their mouths for 20 min. The tracer was injected, and their lung blood flow was imaged. Then, they switched to nasal breathing for 10 min. Tracer was again injected imagery was taken.

The final group was used to see if NO was, in fact, the driver of lung blood flow redistribution. These participants breathed through their mouths but were given supplemental NO. If NO was the driver, mouth breathing with additional NO should result in similar blood flow redistribution as nasal breathing.

They found that nasal breathing redistributed blood flow both vertically and horizontally in the lungs, making it more uniform. The same occurred when mouth breathing with supplemental NO. Thus, NO, whether produced naturally in the nasal passages or supplemented, acts to redistribute blood flow and increase gas exchange in the lungs.

The authors hypothesize that the NO produced in the nasal passages is an evolutionary adaptation to walking upright.  The NO acts to make blood flow and gas exchange more uniform, thus countering the effects of gravity.

In summary, nasal nitric oxide counteracts the effects of gravity and makes lung blood flow more uniform in the upright position. Interestingly, this only occurs in humans and higher primates. Thus, NO production in the upper airways might have been a critical evolutionary adaptation that allowed us to walk upright.

Abstract

There are a number of evidences suggesting that lung perfusion distribution is under active regulation and determined by several factors in addition to gravity. In this work, we hypothesised that autoinhalation of nitric oxide (NO), produced in the human nasal airways, may be one important factor regulating human lung perfusion distribution in the upright position. In 15 healthy volunteers, we used single-photon emission computed tomography technique and two tracers (99mTc and 113mIn) labeled with human macroaggregated albumin to assess pulmonary blood flow distribution. In the sitting upright position, subjects first breathed NO free air through the mouth followed by the administration of the first tracer. Subjects then switched to either nasal breathing or oral breathing with the addition of exogenous NO-enriched air followed by the administration of the second tracer. Compared with oral breathing, nasal breathing induced a blood flow redistribution of approximately 4% of the total perfusion in the caudal to cranial and dorsal to ventral directions. For low perfused lung regions like the apical region, this represents a net increase of 24% in blood flow. Similar effects were obtained with the addition of exogenous NO during oral breathing, indicating that NO and not the breathing condition was responsible for the blood flow redistribution. In conclusion, these results provide evidence that autoinhalation of endogenous NO from the nasal airways may ameliorate the influence of gravity on pulmonary blood flow distribution in the upright position. The presence of nasal NO only in humans and higher primates suggest that it may be an important part of the adaptation to bipedalism.

Journal Reference:

Sánchez Crespo A, Hallberg J, Lundberg JO, Lindahl SG, Jacobsson H, Weitzberg E, Nyrén S.  Nasal nitric oxide and regulation of human pulmonary blood flow in the upright position.  J Appl Physiol.  2010;108:181–188.

The protective role of nitric oxide during adaptation to hypoxia

Key Points

• Adaptation to hypoxia increases NO production and storage

• Simultaneously, adaptation to hypoxia protects against NO over- and under-production

Breathing Blueprint Summary

A paper we recently reviewed found that the production and storage of nitric oxide (NO) increases significantly during adaptation to hypoxia.  This paper wanted to see what would happen during adaptation to hypoxia in disorders of either NO over-production or NO deficiency.

Three different types of Wistar rats were studied.  The first was a model of NO overproduction (NO+), the second a model of NO deficiency (NO-), and the third a control group.

The same protocol from their previous work was used for adaptation to hypoxia: They gradually adapted mice to hypoxia in an altitude chamber simulating ~5000 m (hypobaric hypoxia).  The mice completed 40 sessions.  They started at 10 min the first session, then 20 min the second session, and so on until they reached 5 hours of simulated altitude per session.

After the full acclimation, the control mice nearly doubled their NO metabolites.  Their NO storage had significantly increased as well.  These results indicated that NO production and storage increased due to adaptation to hypoxia.

These adaptations were beneficial for the other mice studied.  The NO+ mice that were not acclimated to hypoxia showed a drop in blood pressure of about 36 mm Hg.  The NO+ mice that were acclimated to hypoxia only showed a 19 mm Hg drop.

Similarly, adaptation to hypoxia protected the NO- mice as well.  Without hypoxia, their blood pressure increased ~80 mm Hg.  With adaptation, it only increased ~20 mm Hg.

These results indicate that adaptation to hypoxia protects against both over- and under-production of NO.

The body ramps up production of NO while simultaneously increasing NO storage to an even greater extent.  This prevents severe drops in blood pressure, but also ensures that NO is available “if needed.”

The final sentence from the abstract sums it up nicely:

“The data suggest that NO stores induced by adaptation to hypoxia can either bind excessive NO to protect the organism against NO overproduction or provide a NO reserve to be used in NO deficiency.”

Abstract

Adaptation to hypoxia is beneficial in cardiovascular pathology related to NO shortage or overproduction. However, the question about the influence of adaptation to hypoxia on NO metabolism has remained open. The present work was aimed at the relationship between processes of NO production and storage during adaptation to hypoxia and the possible protective significance of these processes. Rats were adapted to intermittent hypobaric hypoxia in an altitude chamber. NO production was determined by plasma nitrite/nitrate level. Vascular NO stores were evaluated by relaxation of the isolated aorta to diethyldithiocarbamate. Experimental myocardial infarction was used as a model of NO overproduction; stroke-prone spontaneously hypertensive rats (SHR-SP) were used as a model of NO shortage. During adaptation to hypoxia, the plasma nitrite/nitrate level progressively increased and was correlated with the increase in NO stores. Adaptation to hypoxia prevented the excessive endothelium-dependent relaxation and hypotension characteristic for myocardial infarction. At the same time, the adaptation attenuated the increase in blood pressure and prevented the impairment of endothelium-dependent relaxation in SHR-SP. The data suggest that NO stores induced by adaptation to hypoxia can either bind excessive NO to protect the organism against NO overproduction or provide a NO reserve to be used in NO deficiency.

Journal Reference:

Manukhina EB, Mashina SY, Smirin BV, et al. Role of nitric oxide in adaptation to hypoxia and adaptive defense. Physiol Res. 2000;49(1):89-97.